Universe Pharmaceuticals INC
UPC
$4.20
$0.4010.53%
NASDAQ
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.55M | -6.55M | -2.72M | -2.72M | -357.70K |
| Total Depreciation and Amortization | 124.40K | 124.40K | 125.50K | 125.50K | 128.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.54M | 5.54M | -76.10K | -76.10K | 152.40K |
| Change in Net Operating Assets | -327.00K | -327.00K | 835.10K | 835.10K | 2.48M |
| Cash from Operations | -1.21M | -1.21M | -1.84M | -1.84M | 2.40M |
| Capital Expenditure | -33.80K | -33.80K | -21.80K | -21.80K | -300.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -- | -- | -- |
| Cash from Investing | -33.80K | -33.80K | -21.80K | -21.80K | -300.00 |
| Total Debt Issued | 3.59M | 3.59M | 1.22M | 1.22M | 1.61M |
| Total Debt Repaid | -555.10K | -555.10K | -2.96M | -2.96M | -573.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.03M | 3.03M | -1.74M | -1.74M | 1.04M |
| Foreign Exchange rate Adjustments | 2.90K | 2.90K | -237.80K | -237.80K | 182.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.79M | 1.79M | -3.83M | -3.83M | 3.62M |